Novel biomarkers of resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus
Open Access
- 11 August 2016
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (38) , 61601-61618
Abstract
Sensitivity to PRIMA-1 MET is associated with decreased MGMT in human glioblastoma cells and glioblastoma stem cells irrespective of p53 statusSensitivity to PRIMA-1 MET is associated with decreased MGMT in human glioblastoma cells andKeywords
This publication has 51 references indexed in Scilit:
- IFNβ‐dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damageThe EMBO Journal, 2013
- Vesicular Stomatitis Virus as an Oncolytic Agent against Pancreatic Ductal AdenocarcinomaJournal of Virology, 2012
- High-Risk Human Papillomaviruses Repress Constitutive Kappa Interferon Transcription via E6 To Prevent Pathogen Recognition Receptor and Antiviral-Gene ExpressionJournal of Virology, 2011
- Oncolytic virotherapy for pancreatic cancerExpert Reviews in Molecular Medicine, 2011
- A diverse range of gene products are effectors of the type I interferon antiviral responseNature, 2011
- Some Attenuated Variants of Vesicular Stomatitis Virus Show Enhanced Oncolytic Activity against Human Glioblastoma Cells relative to Normal Brain CellsJournal of Virology, 2010
- Unphosphorylated STAT1 prolongs the expression of interferon-induced immune regulatory genesProceedings of the National Academy of Sciences, 2009
- The Addition of Tumor Necrosis Factor plus Beta Interferon Induces a Novel Synergistic Antiviral State against Poxviruses in Primary Human FibroblastsJournal of Virology, 2009
- An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancerProceedings of the National Academy of Sciences, 2008
- Type I Interferons in the Treatment of Pancreatic CancerAnnals of Surgery, 2007